Invivyd (IVVD) Asset Utilization Ratio (2024 - 2026)
Invivyd's (IVVD) quarterly Asset Utilization Ratio came in at 0.23 in Q2 2026, down 52.51% on a YoY basis from 0.48 in Q2 2025, and down 11.4% quarter-over-quarter from 0.26 in Q4 2025.
Analysis
Invivyd (IVVD) Asset Utilization Ratio (2024 - 2026) Analysis & Trends
Invivyd (IVVD) has reported Asset Utilization Ratio for 3 consecutive years, with 0.23 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Utilization Ratio fell 52.51% year-over-year to 0.23; the trailing twelve-month figure through Jun 2026 stood at 0.23 (down 52.51% YoY), and the FY2025 full-year result was 0.26, up 85.77% from the prior year.
- Asset Utilization Ratio retreated to 0.23 in Q2 2026 per IVVD's latest filing, from 0.26 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.48 in Q2 2025 and bottomed at 0.01 in Q2 2024.
- Historically, Asset Utilization Ratio has averaged 0.25 across 3 years, with a median of 0.24 in 2025.
- The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio soared 4056.76% in 2025, then sank 52.51% in 2026.
- Over 3 years, Asset Utilization Ratio stood at 0.17 in 2024, then soared by 47.44% to 0.26 in 2025, then fell by 11.4% to 0.23 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.23, 0.26, and 0.44 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 0.40 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 0.47 |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 0.38 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 0.20 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 0.90 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 0.33 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 0.54 |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn | 0.23 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.23 |
| Dec 31, 2025 | 0.26 |
| Sep 30, 2025 | 0.44 |
| Jun 30, 2025 | 0.48 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | 0.17 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | 0.01 |